These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24332520)

  • 1. Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system.
    Schiodt M; Reibel J; Oturai P; Kofod T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):204-13. PubMed ID: 24332520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed.
    Fedele S; Bedogni G; Scoletta M; Favia G; Colella G; Agrillo A; Bettini G; Di Fede O; Oteri G; Fusco V; Gabriele M; Ottolenghi L; Valsecchi S; Porter S; Fung PP; Saia G; Campisi G; Bedogni A
    Br J Oral Maxillofac Surg; 2015 Jan; 53(1):13-7. PubMed ID: 25282593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
    Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S
    J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients.
    Ehrenstein V; Gammelager H; Schiødt M; Nørholt SE; Neumann-Jensen B; Folkmar TB; Pedersen L; Svaerke C; Sørensen HT; Ma H; Acquavella J
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):693-700. PubMed ID: 25974710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort.
    Yazdi PM; Schiodt M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):416-22. PubMed ID: 25697927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
    Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA
    Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study.
    Yamazaki T; Yamori M; Ishizaki T; Asai K; Goto K; Takahashi K; Nakayama T; Bessho K
    Int J Oral Maxillofac Surg; 2012 Nov; 41(11):1397-403. PubMed ID: 22840716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
    Bagan JV; Hens-Aumente E; Leopoldo-Rodado M; Poveda-Roda R; Bagan L
    Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of positron emission tomography in osteonecrosis of the jaws?
    Belcher R; Boyette J; Pierson T; Siegel E; Bartel TB; Aniasse E; Stack B
    J Oral Maxillofac Surg; 2014 Feb; 72(2):306-10. PubMed ID: 24075237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw and survival of patients with cancer: a nationwide cohort study in Denmark.
    Corraini P; Heide-Jørgensen U; Schiødt M; Nørholt SE; Acquavella J; Sørensen HT; Ehrenstein V
    Cancer Med; 2017 Oct; 6(10):2271-2277. PubMed ID: 28941210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
    Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
    J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws.
    Lee CY; Pien FD; Suzuki JB
    Implant Dent; 2011 Oct; 20(5):331-6. PubMed ID: 21881516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral health risk factors for bisphosphonate-associated jaw osteonecrosis.
    Tsao C; Darby I; Ebeling PR; Walsh K; O'Brien-Simpson N; Reynolds E; Borromeo G
    J Oral Maxillofac Surg; 2013 Aug; 71(8):1360-6. PubMed ID: 23582590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.